Company / Total Assets
Traws Pharma, Inc. Total Assets History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$10.6M
FY2024
5-year range
$10.6M / $55.5M
FY2020-FY2024
Trend
-53.2%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Total Assets has declined for 3 consecutive years, from $55M in FY2021 to $11M in FY2024.
Based on SEC 10-K filings.
$11M in FY2024 with a 5-year CAGR of -14.8%.
Declined from $39M to $11M over the past 2 years.
Total Assets over time
Growth rates
- 3-Year CAGR
- -42.4%
- 5-Year CAGR
- -14.8%
- 10-Year CAGR
- -
Key checks
Key Insights
- Traws Pharma, Inc.'s total assets has declined for 3 consecutive years.
- 5-year CAGR of -14.8%, indicating a declining trend.
- In FY2024, total assets decreased 53.2% year-over-year.
- Peak total assets was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score -42.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $10.6M | -53.2% |
| FY2023 | $22.7M | -42.4% |
| FY2022 | $39.4M | -29.0% |
| FY2021 | $55.5M | +177.6% |
| FY2020 | $20.0M | -15.6% |
| FY2019 | $23.7M | +32.1% |
| FY2018 | $17.9M | +260.0% |
| FY2017 | $5.0M | -78.6% |
| FY2016 | $23.2M | -0.9% |
| FY2015 | $23.4M | -50.5% |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026